Objectives: During the lecture we will review the latest developments in:
a) Androgenetic alopecia: we will discuss the use of oral minoxidil (0.5-1 mg daily in females, 2.5-5 mg daily in males), oral dutasteride for male androgenetic alopecia, oral bicalutamide for female androgenetic alopecia, topical clascoterone and some news about the stem cell therapy.
Introduction: b) Alopecia areata: we will talk about the JAK inhibitors and other new molecules, as well as the potential relevance of the gut microbiome in patients with extensive alopecia areata and how its modulation may represent another new therapeutic strategy.
c) Chemotherapy-induced alopecia: we will review the latest articles about the effectiveness and safety of the scalp cooling devices in the prevention of the chemotherapy-induced anagen effluvium.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。